PANGRAF 0.5MG CAP

About

Tacrolimus is a highly potent calcineurin inhibitor, a class of immunosuppressant medications critical for preventing organ rejection in patients who have received a kidney, liver, or heart transplant. Its primary mechanism involves binding to an intracellular protein, FKBP-12, and the resulting complex then inhibits calcineurin, a crucial phosphatase. This inhibition prevents the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells), thereby blocking its translocation into the nucleus and the subsequent transcription of various cytokine genes, including interleukin-2. These cytokines are essential for T-lymphocyte activation and proliferation, which are central to the immune response against transplanted organs. By effectively suppressing T-cell activation, tacrolimus significantly reduces the body's ability to reject the new organ. It is typically used in combination with other immunosuppressive agents and requires careful therapeutic drug monitoring to maintain optimal blood levels and minimize the risk of toxicity while ensuring adequate immunosuppression.

Uses

• Prevention of liver transplant rejection.
• Prevention of kidney transplant rejection.
• Prevention of heart transplant rejection.
• Treatment of certain autoimmune diseases (off-label).

Directions For Use

Take orally, usually once or twice daily, on an empty stomach or consistently with food as directed by your physician. Swallow capsules whole.

Benefits

• Highly effective in preventing organ rejection.
• Potent immunosuppressive action.
• Improves long-term graft and patient survival.
• Reduces the incidence of acute rejection episodes.
• Often used as a cornerstone of immunosuppressive therapy.
• Available in various formulations for flexible dosing.

Side Effects

• Tremor
• Headache
• Hypertension (high blood pressure)
• Nephrotoxicity (kidney damage)
• Hyperglycemia (high blood sugar/diabetes)
• Nausea and diarrhea
• Insomnia
• Paresthesia (tingling/numbness)
• Hyperkalemia (high potassium)
• Increased risk of infections
• Increased risk of malignancies (e.g., lymphoma)
• Alopecia (hair loss)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may increase the risk of liver toxicity and exacerbate gastrointestinal side effects.
• Pregnancy - Use in pregnancy only if the potential benefit justifies the potential risk to the fetus; careful monitoring is required.
• Breastfeeding - Not recommended during breastfeeding as tacrolimus is excreted in breast milk and can cause serious adverse effects in the infant.
• Liver - Use with extreme caution in patients with severe liver impairment; significant dose reductions are often necessary due to altered metabolism.
• Kidney - Use with caution in patients with pre-existing kidney impairment due to its nephrotoxic potential; close monitoring of renal function is essential.
• Lung - Monitor for pulmonary toxicity, including interstitial lung disease, though rare; generally safe for underlying lung conditions with careful observation.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.